Dr. Michael J. Thun, vice president of epidemiology and surveillance research at the American Cancer Society, agreed that the findings were interesting but don't prove a connection between prostate cancer and Agent Orange.
"The finding is provocative, but it's hard to know how to interpret it, unless it can be replicated in other studies," Thun said.
More information
For more on prostate cancer, visit the American Cancer Society .
SOURCES: Karim Chamie, M.D., resident physician in urology, VA Northern California Health Care System; Bruce Roth, M.D., professor, medicine and urologic surgery, Vanderbilt University, Nashville, Tenn.; Michael J. Thun, M.D., vice president of epidemiology and surveillance research, American Cancer Society, Atlanta; Sept. 15, 2008, Cancer, early online release